Validation of a Prediction Model for Inadequate Bowel Preparation

May 27, 2024 updated by: Xingshun Qi, General Hospital of Shenyang Military Region

Validation of a Prediction Model for Inadequate Bowel Preparation Before Colonoscopy Based on a Systematic Review and Meta-analysis

We have developed a novel inadequate bowel preparation prediction model based on a systematic review and meta-analysis. The goal of this observational study is to validate the accuracy of this model.

Study Overview

Status

Recruiting

Detailed Description

A total of 615 patients undergoing colonoscopy will be enrolled. The primary outcome is quality of bowel preparation. The secondary outcomes include polyp/adenoma detection rate, willingness of undergoing colonoscopy again and adverse events.

Study Type

Observational

Enrollment (Estimated)

615

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Liaoning
      • Shenyang, Liaoning, China, 110840
        • Recruiting
        • Department of Gastroenterology, General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area)
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Adult patients undergoing colonoscopy

Description

Inclusion Criteria:

  1. adult patients (age is ≥18 years old);
  2. patients undergoing colonoscopy;
  3. written informed consent.

Exclusion Criteria:

  1. patients undergoing emergent colonoscopy;
  2. patients with major psychiatric disorders;
  3. pregnant or breast feeding patients;
  4. patients with contraindications for colonoscopy (e.g., heart failure, renal insufficiency);
  5. patients suspected to have intestinal obstruction, stenosis or perforation;
  6. patients previously enrolled in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients undergoing colonoscopy
Patients were informed to eat semi-liquid and non-slag diet for breakfast and lunch and full-liquid diet for dinner on the day before colonoscopy, and be fasting on the day of colonoscopy. A split-dose 3 L PEG regimen was used for all patients.
Patients use purgative for bowel cleansing before colonoscopy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of bowel preparation
Time Frame: During the procedure of colonoscopy
A total BBPS score ≥6 with BBPS score ≥2 for each colon segment was considered to have adequate bowel preparation.
During the procedure of colonoscopy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adenoma and/or polyp detection rate
Time Frame: During the procedure of colonoscopy
Proportion of patients with at least one adenoma and/or polyp detected during colonoscopy
During the procedure of colonoscopy
Number of polyps and/or adenomas
Time Frame: During the procedure of colonoscopy
Number of polyps and/or adenomas detected during colonoscopy
During the procedure of colonoscopy
Adverse events
Time Frame: Before the procedure of colonoscopy
Incidence of abdominal pain, bloating, nausea/vomiting after intake of PEG.
Before the procedure of colonoscopy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xingshun Qi, Department of Gastroenterology, General Hospital of Northern Theater Command

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 6, 2024

Primary Completion (Estimated)

September 30, 2024

Study Completion (Estimated)

December 30, 2024

Study Registration Dates

First Submitted

May 27, 2024

First Submitted That Met QC Criteria

May 27, 2024

First Posted (Actual)

May 31, 2024

Study Record Updates

Last Update Posted (Actual)

May 31, 2024

Last Update Submitted That Met QC Criteria

May 27, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • V-PMIBP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonoscopy

Clinical Trials on Bowel preparation before colonoscopy

3
Subscribe